bioAffinity Technologies (BIAF) Change in Account Payables (2021 - 2026)
bioAffinity Technologies has reported Change in Account Payables over the past 5 years, most recently at $74310.0 for Q1 2026.
- Quarterly Change in Account Payables fell 81.15% to $74310.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$545367.0 through Mar 2026, down 154.67% year-over-year, with the annual reading at -$225410.0 for FY2025, 158.93% down from the prior year.
- Change in Account Payables was $74310.0 for Q1 2026 at bioAffinity Technologies, up from -$178860.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $577474.0 in Q3 2023 and troughed at -$435285.0 in Q3 2022.
- The 5-year median for Change in Account Payables is $17284.0 (2022), against an average of $19503.2.
- Year-over-year, Change in Account Payables tumbled 1248.49% in 2023 and then surged 1565.44% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $195360.0 in 2022, then plummeted by 315.67% to -$421337.0 in 2023, then skyrocketed by 148.51% to $204373.0 in 2024, then tumbled by 187.52% to -$178860.0 in 2025, then skyrocketed by 141.55% to $74310.0 in 2026.
- Per Business Quant, the three most recent readings for BIAF's Change in Account Payables are $74310.0 (Q1 2026), -$178860.0 (Q4 2025), and -$229076.0 (Q3 2025).